Caliway Biopharmaceuticals Announces Successful EOP2 Meeting with the FDA for CBL-514 in Reduction of Abdominal Subcutaneous Fat
Caliway has completed the End-of-Phase 2 (EOP2) meeting with the [...]
Caliway has completed the End-of-Phase 2 (EOP2) meeting with the [...]
The EIC Soft-landing Programme provides business development support and opportunities [...]
BD SpectralFX Technology maximizes the number of colors that can [...]
Addition of commercial-scale sterile injectables capabilities in Lexington, KY.
Operational expansion accelerates global distribution capability to increase regional access [...]
Researchers and scientists must invest wisely in the tools they [...]
Collaboration will deliver innovative AI-powered pathology tools and quality control [...]
The Institutional Review Board Has Approved the Increase in Number [...]
As this biomarker can be detected in blood, this test [...]
The presentation is scheduled for April 23, 2025, at 12:25 [...]